Convulsiones

ALA is the essential plant-based omega-3 fatty acid and the dietary precursor to EPA and DHA, though conversion is limited (less than 5–15%). The NIH ODS establishes an Acceptable Macronutrient Distribution Range for ALA (0.6–1.2% of energy) during pregnancy. ALA is the primary omega-3 source for vegetarian/vegan pregnant women, with dietary guidance emphasizing adequate ALA intake alongside pre-formed DHA supplementation to meet fetal neurodevelopment needs.

Algal oil is the primary plant-based (vegan-friendly) source of long-chain omega-3 DHA for prenatal supplementation. Clinical studies confirm algal oil DHA supplementation during pregnancy raises maternal and fetal DHA status equivalently to fish oil. It is recommended by ACOG and dietary guidelines as the sustainable, contaminant-free DHA source for vegetarian and vegan pregnant women and is used in many commercial prenatal vitamins.

Asparagus officinalis is one of the richest dietary sources of folate, with a half-cup providing approximately 134 mcg (roughly 33% of the recommended 400 mcg daily, and higher portions approaching the 600 mcg prenatal recommendation). Adequate folate is established by mainstream medical and nutritional authorities to reduce neural tube defects such as spina bifida. This is a well-established nutritional relationship.

Beta-carotene is the provitamin A carotenoid used safely in prenatal supplements as an alternative to preformed retinol, which is teratogenic at high doses. As a regulated precursor to vitamin A, it supports fetal organogenesis, immune function, and vision without teratogenic risk. The NIH ODS specifically notes that the UL for vitamin A during pregnancy does not apply to beta-carotene, making it the preferred prenatal vitamin A source.

Bifidobacterium species are key prenatal and neonatal microbiome components. Maternal supplementation during pregnancy with Bifidobacterium strains has been studied for reducing gestational diabetes, preterm birth complications, and establishing neonatal gut colonization with health-promoting bacteria. Systematic reviews of probiotics in pregnancy consistently include Bifidobacterium-containing formulations among the most studied and promising interventions.

Bifidobacterium lactis (B. animalis subsp. lactis, particularly strain BB-12) is one of the most widely used probiotic strains in pregnancy research. In a landmark Finnish RCT, formulations including B. lactis BB-12 significantly reduced GDM incidence (13% vs. 36%, p=0.003). It has also demonstrated improved neonatal gut colonization and reduced infantile atopic disease in multiple RCTs.

Bifidobacterium longum is a probiotic species studied in prenatal formulations for reducing gestational diabetes, improving maternal gut microbiome composition, and colonizing the neonatal gut with health-promoting bacteria. As a component of multi-strain probiotic supplements used in pregnancy RCTs, B. longum contributes to reductions in GDM risk and neonatal atopic disease seen in systematic reviews.

Bovine liver is exceptionally rich in folate, B12, heme iron, choline, and preformed vitamin A — nutrients that are critical for fetal neural tube development, brain formation, and prevention of maternal anemia. Folate reduces neural tube defect (NTD) risk; choline and B12 are critical for fetal brain development. However, excessive preformed vitamin A from liver can be teratogenic at high doses.

Broccoli is a rich dietary source of folate (vitamin B9), which is essential for fetal neural tube development. Adequate folate intake from foods including broccoli is a well-established public health recommendation to prevent neural tube defects in early pregnancy.

Brussels sprouts are a meaningful source of folate (vitamin B9), which is essential for fetal neural tube development, DNA synthesis, and cell division. Adequate folate intake before and during early pregnancy is a well-established strategy for preventing neural tube defects such as spina bifida.

DHA is essential for fetal brain and retinal development, and calamari oil's high DHA content directly supports this need. Prenatal DHA supplementation is widely recommended and studied in RCTs. DHA is selectively concentrated in fetal brain and retinal tissues during the third trimester, and lower maternal DHA levels are linked to adverse neurodevelopmental and mood outcomes.

Calcium is critical for fetal skeletal development and is recommended by WHO, ACOG, and multiple professional societies for pregnant women with low dietary intake to reduce preeclampsia risk. Calcium supplementation of 1,500–2,000 mg/day reduces preeclampsia incidence significantly in RCTs. About 21.2% of US pregnant women have dietary calcium intakes below the estimated average requirement, and NIH ODS specifically lists calcium among critical prenatal nutrients.

Vitamin A—supplied via dietary beta-carotene—is essential during pregnancy for fetal organogenesis including development of the eyes, lungs, heart, and nervous system. Beta-carotene is recommended as a safer provitamin A source in pregnancy because, unlike preformed vitamin A, it does not carry teratogenic risk at high intakes. Deficiency is associated with night blindness, anemia, and increased infant mortality.

Cauliflower provides two key prenatal nutrients: folate (vitamin B9) and choline. Folate is essential for neural tube closure; cauliflower is a documented dietary source. Choline is critical for fetal brain development and membrane formation, and approximately 90–95% of pregnant women fail to meet the recommended intake.

A clinical trial in pregnant Japanese women demonstrated that daily chlorella supplementation significantly reduced the incidence of pregnancy-associated anemia, proteinuria, and edema. Chlorella's high content of folate, iron, and vitamin B12 supports its use as a prenatal micronutrient source.

Choline is recognized as an essential nutrient critical for fetal neural tube formation, brain development, and placental function. ACOG specifically recommends choline supplementation during pregnancy; over 90–95% of US pregnant women fail to meet the AI of 450 mg/day. Lower circulating choline is associated with increased NTD risk (meta-analysis finding), and prenatal choline supports fetal neurodevelopment in systematic reviews. NIH ODS lists choline among critical prenatal nutrients.

DHA from cod liver oil supports fetal brain and retinal development; vitamin D supports fetal bone mineralization. CLO use during pregnancy has been associated with reduced perinatal complications in gestational diabetes. Evidence from a Norwegian study links prenatal CLO use with lower type 1 diabetes risk in offspring.

Collard greens are among the best natural sources of folate, and adequate folate intake during early pregnancy is strongly evidence-based to prevent neural tube defects such as spina bifida. Doctors recommend at least 400mcg folate daily for women who may become pregnant. Collards also provide iron, calcium, and vitamin C relevant to maternal and fetal health.

Copper is an essential nutrient during pregnancy, required for fetal brain, heart, vascular, skeletal, and immune development. Maternal copper requirements increase during gestation. Low maternal serum copper has been associated with premature delivery and impaired fetal growth indices. Copper deficiency during embryogenesis causes gross structural and biochemical abnormalities.

Alpha-tocopherol is recognized as essential for normal fetal development, particularly through the alpha-tocopherol transfer protein (TTPA) which actively concentrates it at the placenta. Severe deficiency is associated with fetal reabsorption in animals and neural tube defects in rodents; human evidence is more limited, and high-dose supplementation in pregnancy is not recommended beyond correcting deficiency.

DHA is the primary structural omega-3 fatty acid in fetal brain and retinal membranes, critical during third-trimester brain growth. The NIH ODS and ACOG list omega-3 fatty acids/DHA among nutrients underconsumed during pregnancy. A Cochrane meta-analysis of 70 RCTs (19,927 participants) found omega-3 (mainly DHA) supplementation reduced preterm births before 34 weeks by 42%. ACOG and Dietary Guidelines for Americans recommend 250–375 mg EPA+DHA/day for pregnant women.

DHA is a critical structural nutrient for fetal brain and retinal development, accumulating rapidly in neural and retinal tissue during the third trimester. Maternal DHA supplementation is associated with improved infant neurodevelopment and visual acuity. International guidelines recommend 200 mg/day DHA from mid-pregnancy.

Eggs are a leading dietary source of choline, DHA, lutein, zeaxanthin, and folate co-factors critical for fetal brain and neural tube development. A Cornell University RCT demonstrated that higher maternal choline intake during the third trimester produces measurably faster infant information processing, a cognitive indicator, and analyses of prenatal nutritional data link egg intake to fetal brain maturation scores.

EPA is studied alongside DHA in prenatal supplementation for maternal and fetal outcomes including inflammation, lipid profiles, and neurodevelopmental support. EPA specifically contributes anti-inflammatory actions during pregnancy. DHA is the primary omega-3 for fetal brain development, but EPA plays a complementary anti-inflammatory and triglyceride-lowering role.

EPA is a long-chain omega-3 fatty acid co-supplemented with DHA in prenatal formulations. Evidence from RCTs and meta-analyses shows combined EPA+DHA supplementation during pregnancy reduces preterm birth risk and postpartum depression through anti-inflammatory mechanisms. EPA plays an important role in facilitating DHA transfer across the placenta. ACOG and dietary guidelines recommend combined EPA+DHA intake for pregnant women.

Fava beans are an exceptionally rich source of folate and iron, both of which are essential for healthy fetal development and prevention of maternal anemia. One cup of cooked fava beans provides approximately 40–50% of the daily folate requirement. WHO recommends daily folate and iron intake during pregnancy to prevent neural tube defects and anemia.

Fish oil is the most-studied source of prenatal omega-3 DHA and EPA. A Cochrane meta-analysis of 70 RCTs involving 19,927 pregnant women found omega-3 (fish oil) supplementation reduced preterm births before 34 weeks by 42% and reduced low birthweight. ACOG recommends 250–375 mg EPA+DHA per day during pregnancy, with fish oil supplements as the primary alternative for women with limited seafood intake.

Folic acid is the most established prenatal nutrient, with strong evidence from RCTs and observational studies showing periconceptional supplementation (400–800 µg/day) reduces neural tube defect (NTD) risk by more than 70%. The NIH ODS, WHO, ACOG, and NICE all recommend routine supplementation before and during early pregnancy. It also reduces megaloblastic anemia risk and may lower preeclampsia and preterm birth risk.

Folate, including folinic acid, is essential for periconceptional supplementation to reduce neural tube defect (NTD) risk. The WHO recommends 400 µg/day of folate before and during early pregnancy. High-risk groups (e.g., prior NTD-affected pregnancy) are advised to take 4–5 mg/day. Folinic acid bypasses the DHFR enzyme step, making it a bioavailable alternative to folic acid for supporting fetal development.

Garbanzo beans are one of the richest plant-food sources of folate (vitamin B9), the key nutrient for preventing neural tube defects in the developing fetus, as well as iron (≈4.7 mg/cup cooked, ~26% DV) essential for maternal erythropoiesis and fetal development. Half a cup of chickpea flour provides approximately 50% of the daily folate value.

Ginger is among the best-evidenced nonpharmacological treatments for nausea and vomiting of pregnancy (NVP). Multiple systematic reviews and RCTs support its efficacy. ACOG states ginger has shown beneficial effects for NVP and considers it a nonpharmacological option; UK NICE includes ginger among acceptable therapies for early pregnancy NVP. An RCT (n=291) found ginger equivalent to vitamin B6 (75 mg/day) for nausea, retching, and vomiting.

Myo-inositol has been included in evidence-based prenatal supplement recommendations for its roles in neural tube defect prevention and gestational diabetes risk reduction. Multiple Italian RCTs of myo-inositol supplementation (2–4 g/day) during pregnancy demonstrate significant reductions (approximately 50%) in gestational diabetes risk. The NIH-funded evidence-based prenatal supplement review (PMC 9275129, 2022) specifically included inositol in prenatal supplementation recommendations.

Iodine is essential for maternal thyroid hormone production, which drives fetal CNS myelination and brain development. Maternal iodine deficiency is associated with miscarriage, stillbirth, congenital hypothyroidism, and irreversible cognitive impairment in offspring. WHO, ACOG, NICE, and NIH ODS all recommend iodine supplementation during pregnancy. NIH ODS lists iodine among nutrients with critical prenatal roles that are underconsumed.

Iron is a universally recommended prenatal supplement: requirements nearly double during pregnancy to support expanded blood volume, placental development, and fetal iron stores. RCTs confirm iron supplementation prevents iron-deficiency anemia, the most common cause of anemia in pregnancy, which is linked to preterm birth, low birthweight, and impaired infant cognitive development. WHO, ACOG, and NIH ODS all recommend routine iron supplementation during pregnancy.

Kelp is one of the richest natural sources of iodine, an essential nutrient for fetal brain and thyroid development. NIH ODS confirms iodine sufficiency during pregnancy is critically important for proper fetal development; severe deficiency causes irreversible neurodevelopmental damage. Kelp-derived iodine can contribute meaningfully to meeting the increased maternal requirement of 220–250 µg/day.

Multiple RCTs and meta-analyses show that prenatal oral L-arginine in high-risk pregnancies significantly reduces rates of intrauterine growth retardation, preterm birth, and respiratory distress syndrome while increasing birthweight, gestational age, and Apgar scores. L-arginine also reduces risk of preeclampsia and lowers blood pressure in women with hypertensive disorders of pregnancy.

Lactobacillus acidophilus is a probiotic strain included in several prenatal probiotic formulations with evidence for reducing gestational diabetes risk, improving maternal gut microbiome composition, and potentially reducing neonatal atopic disease risk. Multiple systematic reviews of probiotics in pregnancy include L. acidophilus-containing interventions among the beneficial formulations studied.

Lactobacillus crispatus is considered one of the most protective vaginal Lactobacillus species during pregnancy; a dominant L. crispatus vaginal environment is associated with significantly reduced risk of preterm birth, bacterial vaginosis, and ascending infections. Its importance is supported by multiple observational cohort studies and emerging RCT data on vaginal probiotic interventions.

Depletion of L. jensenii in the vaginal microbiome during pregnancy is associated with preterm birth and spontaneous rupture of membranes. A 2023 genomic profiling study found L. jensenii strains from preterm pregnancies are phylogenetically distinct from those of full-term pregnancies, with strain-specific genetic signatures potentially linked to adverse outcomes. The evidence underscores that strain identity, not just species presence, matters in prenatal contexts.

Lactobacillus reuteri is a probiotic strain with evidence from RCTs for reducing neonatal outcomes including colic and atopic disease when supplemented during pregnancy. Maternal supplementation has also been studied for colonization effects, Group B Streptococcus (GBS) reduction during pregnancy, and multi-strain probiotic formulations containing L. reuteri have been shown in meta-analyses to reduce GDM risk.

Lactobacillus rhamnosus (particularly strain GG) is one of the most-studied probiotic strains in pregnancy, with RCT evidence supporting reductions in gestational diabetes mellitus risk, preterm birth-associated complications, and neonatal atopic disease. A landmark RCT found L. rhamnosus GG significantly reduced GDM incidence (13% vs. 36%, p=0.003) from first trimester supplementation. International expert consensus (2025) included probiotics among supplements reviewed for pregnancy.

Lactoferrin is an iron-binding glycoprotein with evidence from multiple RCTs for improving iron status and reducing iron-deficiency anemia in pregnancy with fewer GI side effects than ferrous sulfate. A systematic review of 9 RCTs found bovine lactoferrin supplementation significantly improved hemoglobin, ferritin, and transferrin saturation compared to ferrous sulfate. Additional evidence suggests lactoferrin supplementation may reduce preterm birth and neonatal infection risk.

Magnesium is an essential mineral for muscle relaxation, bone development, and blood pressure regulation during pregnancy, with levels declining if unsupplemented. Inadequate magnesium intake is linked to gestational diabetes, preeclampsia, preterm birth, and low birthweight. A Cochrane review found magnesium supplementation was associated with significant reduction in low birthweight risk. NIH ODS lists magnesium among critical prenatal nutrients underconsumed by pregnant women.

Adequate MeCbl (as the active form of B12) is essential during pregnancy for fetal brain development, myelination, DNA methylation, and prevention of neural tube defects. Maternal B12 deficiency is associated with impaired placental development, adverse neurodevelopmental outcomes in offspring, and megaloblastic anemia. MeCbl has been used prenatally in cases of maternal cobalamin metabolic defects.

Okra is a notable dietary source of folate, essential for neural tube development, DNA synthesis, and fetal brain and spinal cord formation. A PMC-indexed study examined okra's impact on the nutritional status of pregnant women in Ethiopia. Okra has also been used traditionally by pregnant women across Africa for various gestational complaints.

Omega-3 fatty acids (primarily DHA and EPA) are widely recommended during pregnancy by NIH ODS, ACOG, and WHO (conditional) to support fetal brain and eye development, reduce preterm birth risk, and lower postpartum depression risk. A Cochrane meta-analysis of 70 RCTs (19,927 participants) found omega-3 supplementation reduced preterm births before 34 weeks by 42%. NIH ODS lists omega-3 fatty acids among nutrients with critical prenatal roles that are underconsumed.

Red palm oil supplementation during pregnancy has been shown in clinical trials to significantly improve maternal vitamin A status, reduce vitamin A deficiency rates, and lower anemia prevalence. Maternal RPO consumption also increases provitamin A carotenoids transferred to the fetus and subsequently to breast milk, benefiting infant micronutrient status.

Vitamin A (as retinyl palmitate) is an essential micronutrient during pregnancy for embryological development, organogenesis, and fetal immune system maturation. WHO recommendations address maternal vitamin A supplementation, particularly in deficiency settings.

Peanuts are rich in folate (up to 60% RDA per 100 g), providing a key nutrient for preventing neural tube defects and supporting fetal brain development. Adequate folate intake during pregnancy is robustly linked to reduced neural tube defect risk, recognised by the WHO. Peanuts also provide iron, magnesium, and B vitamins relevant in pregnancy.

PC is the primary dietary form of choline, an essential nutrient for fetal brain development, membrane biosynthesis, and epigenetic programming. Pregnancy dramatically increases demand for PC/choline for fetal tissue expansion and neurodevelopment. Maternal PC supplementation has been studied in RCTs for infant neurocognitive outcomes.

Phosphorus is essential for fetal skeletal ossification, ATP production, and cellular development. During pregnancy, phosphate homeostasis is significantly altered, and adequate intake supports fetal bone and organ development. Preterm infants particularly face risk from inadequate calcium-phosphorus supply.

Progesterone is essential for pregnancy maintenance, preventing preterm labor, and supporting implantation. Vaginal progesterone reduces preterm birth risk in women with a short cervix. Progestogen supplementation is standard in IVF luteal phase support and is used to prevent recurrent miscarriage in high-risk women.

Raspberry leaf is the most widely used herbal supplement in pregnancy and has been the subject of multiple clinical studies examining labor outcomes. A 2024 prospective observational study (n=91) found raspberry leaf strongly predictive of women not requiring medical augmentation of labor, with shorter labor phases and lower rates of cesarean section. A 2000 retrospective study of 108 women found no identified side effects and a suggestion of reduced pre/post-term gestation. However, a 2021 systematic integrative review concluded the evidence base is weak and an RCT is urgently needed.

Selenium is an essential trace mineral with critical roles in antioxidant defense via glutathione peroxidases, thyroid hormone metabolism, and immune function. Blood selenium levels decline during pregnancy without supplementation. Poor selenium status is associated with miscarriage, preeclampsia, preterm delivery, and gestational diabetes. Evidence-based prenatal supplement recommendations (PMC 8229801, 2021) specifically recommended selenium supplementation during pregnancy.

Spinach is a primary dietary source of folate, essential for neural tube closure and fetal DNA synthesis. Folate adequacy during periconceptional period and early pregnancy is established by strong clinical evidence to prevent neural tube defects. Spinach also provides iron, needed for expanded maternal erythropoiesis during pregnancy.

Vitamin A is essential for fetal organogenesis, immune function, and vision development, with blood levels declining during pregnancy without supplementation. WHO recommends vitamin A supplementation in deficiency areas to reduce maternal night blindness and infant mortality. NIH ODS lists vitamin A among nutrients with critical prenatal roles. Care is taken to stay below the teratogenic UL of 3,000 mcg RAE/day for preformed vitamin A.

Thiamine (vitamin B1) is essential for carbohydrate metabolism and neural development, with blood levels declining during pregnancy. An international expert Delphi consensus panel (PMC 11744953, 2025, n=35 experts) listed thiamine among micronutrients important during pregnancy. Deficiency in pregnancy can cause Wernicke's encephalopathy and is associated with fetal cardiac and neurological abnormalities; it is especially critical in women with hyperemesis gravidarum.

Vitamin B12 is critical during pregnancy for hematopoiesis, myelination, and DNA methylation; deficiency is associated with NTDs, preeclampsia, low birthweight, and cognitive deficits in offspring. A systematic review of 7 RCTs found beneficial effects of B12 supplementation on offspring neurocognitive development. NIH ODS and ACOG list vitamin B12 as a critical prenatal nutrient, especially important for vegetarian and vegan pregnant women.

Riboflavin (vitamin B2) is essential for energy metabolism and fetal growth, with blood levels declining during pregnancy without supplementation. The WHO UNIMMAP multi-micronutrient supplement for pregnancy includes riboflavin, and an international expert consensus panel (2025) listed it among important prenatal micronutrients. Observational studies have associated low riboflavin intake with increased preeclampsia risk; the RDA increases to 1.4 mg/day during pregnancy.

Niacin (vitamin B3) is a precursor to NAD+, and deficiency during pregnancy has been linked to miscarriage and multiple congenital malformations via NAD+ deficiency in a landmark 2018 NEJM study. Blood niacin levels decrease during pregnancy without supplementation. An evidence-based prenatal supplement review (PMC 9275129, 2022) recommended niacin supplementation; the RDA increases to 18 mg NE/day during pregnancy.

Niacinamide (nicotinamide, the amide form of niacin B3) is the form most commonly used in prenatal vitamins due to its absence of vasodilatory flushing. As an NAD+ precursor, it is critical for fetal DNA repair and energy metabolism during organogenesis. A landmark 2018 NEJM study found maternal NAD+ deficiency from niacin/nicotinamide deficiency causes congenital malformations; niacinamide rescued this phenotype in mice.

Vitamin B5 (pantothenic acid) is a component of coenzyme A essential for fatty acid synthesis and energy metabolism. Blood levels decline during pregnancy without supplementation. An evidence-based review of 188 prenatal supplements (PMC 9275129, 2022) identified pantothenic acid among vitamins that decline during pregnancy and recommended it for prenatal supplementation. The AI increases to 6 mg/day during pregnancy.

Vitamin B6 (pyridoxine) has established evidence for reducing nausea severity in early pregnancy and is recommended by ACOG as a first-line nonpharmacological option for pregnancy nausea and vomiting. NIH ODS and WHO both recognize its role in pregnancy, and it is listed among nutrients underconsumed during pregnancy. A Cochrane review supports its use for nausea management; an RCT (n=291) found it equivalent to ginger (75 mg/day) for NVP reduction.

Biotin (vitamin B7) levels decrease substantially during pregnancy; approximately half of US pregnant women show biomarkers of mild biotin deficiency. Animal studies demonstrate biotin deficiency during pregnancy may cause birth defects including facial and limb malformations and impaired fetal development. An evidence-based prenatal supplement review (PMC 9275129, 2022) recommended approximately 100 mcg/day biotin supplementation during pregnancy.

Folate (natural food-form vitamin B9) is essential for fetal neural tube closure, DNA synthesis, and cell division during pregnancy. The NIH ODS specifically lists folate/folic acid among nutrients with critical prenatal roles that are underconsumed. Adequate periconceptional folate reduces NTD risk by over 70% and supports prevention of megaloblastic anemia. The RDA increases to 600 mcg DFE/day during pregnancy.

5-Methyltetrahydrofolate (5-MTHF) is the biologically active circulating form of folate used in prenatal supplements, especially for women with MTHFR gene variants that reduce folic acid conversion efficiency. Clinical trials show it effectively raises serum folate levels. EU and several national health authorities have approved 5-MTHF as a bioequivalent alternative to folic acid for NTD risk reduction during pregnancy.

Vitamin C is listed by NIH ODS and ACOG among nutrients with critical roles during pregnancy. Blood levels decline during pregnancy without supplementation. Vitamin C substantially enhances non-heme iron absorption—clinically important for preventing iron-deficiency anemia in pregnancy. Small intervention studies suggest it may reduce risk of premature rupture of membranes and urinary tract infections, though high-dose combinations with vitamin E for preeclampsia have not shown benefit.

Vitamin D is among the most studied prenatal micronutrients, essential for calcium absorption, fetal skeletal development, immune function, and fetal brain development. Severe deficiency causes maternal and fetal rickets; observational and RCT evidence links deficiency to gestational diabetes, preeclampsia, preterm birth, and neurodevelopmental disorders in offspring. Vitamin D insufficiency affects up to 47.9% of individuals globally, with especially high rates in pregnant women. WHO, ACOG, and NICE all give conditional-to-strong recommendations for prenatal supplementation.

Vitamin D3 (cholecalciferol) is the most bioavailable and clinically preferred form of vitamin D for prenatal supplementation, demonstrating superior ability to raise serum 25(OH)D levels compared to D2. Used in the majority of prenatal RCTs, it supports fetal skeletal development, reduces preeclampsia risk, and supports neonatal immune and neurodevelopmental outcomes. ACOG and NICE specifically reference vitamin D3 in their prenatal supplementation contexts.

Vitamin E is a fat-soluble antioxidant whose blood levels decline during pregnancy without supplementation. A Mendelian randomization study (2024, UK Biobank + FinnGen) found genetically predicted higher vitamin E levels were inversely associated with spontaneous abortion risk (OR=0.993, p=0.005). It is included in prenatal supplement recommendations. However, high-dose supplemental vitamin E combined with vitamin C for preeclampsia prevention is not recommended based on large RCT evidence.

Vitamin K plays critical roles in fetal bone development and coagulation factor synthesis. Blood levels decline during pregnancy without supplementation. It is included in evidence-based prenatal supplement reviews and in international expert consensus recommendations for pregnancy. Neonates are routinely given vitamin K at birth to prevent hemorrhagic disease, and maternal vitamin K status during pregnancy affects neonatal coagulation and bone development.

Wheat germ is a significant natural source of folate (folic acid), iron, zinc, and B vitamins essential for fetal development and maternal health. Adequate periconceptional folate reduces neural tube defect risk by up to 80%. Wheat germ's folate, iron, and B-vitamin content directly supports established prenatal nutritional requirements.

Zinc is critical for cell division, immune function, and fetal growth; deficiency is associated with intrauterine growth restriction, preterm birth, and congenital malformations. NIH ODS lists zinc among nutrients with critical prenatal roles that are underconsumed. A Cochrane systematic review of zinc supplementation in pregnancy found significant reductions in preterm birth (RR 0.86). RDA increases to 11 mg/day during pregnancy.

Colostrum (first milk after delivery) has been used traditionally across cultures to support neonatal immune function and gut health in the immediate postnatal period. Bovine colostrum supplementation during pregnancy has been studied in small trials for supporting maternal immune function and gut integrity, though evidence is limited and insufficient for specific prenatal health recommendations beyond its postnatal neonatal use.

Eucommia bark is documented in the Chinese Pharmacopoeia specifically for 'calming the fetus' and preventing threatened miscarriage and pregnancy bleeding. It is a classical TCM herb for pregnancy support, with uterine-stabilizing properties attributed to it for over 2,000 years. Scientific studies on this indication are absent.